HIA
BIIB icon

HFM Investment Advisors’s Biogen BIIB Stock Holding History

HFM Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$917 Hold
5
– – ﹤0.01% 441
2025
Q4 		$880 Buy
5
+4
+400% +$653 ﹤0.01% 499
2025
Q3 		$140 Sell
1
-1
-50% -$135 ﹤0.01% 1088
2025
Q2 		$251 Buy
2
+1
+100% +$125 ﹤0.01% 914
2025
Q1 		$137 Buy
+1
New +$143 ﹤0.01% 767

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HFM Investment Advisors's BIIB Position: Q1 2026 in Review

HFM Investment Advisors held its Biogen (BIIB) position steady in Q1 2026 at 5 shares worth $917. The position accounts for ﹤0.01% of the portfolio, ranked #441.

HFM Investment Advisors first reported a position in BIIB in Q1 2025 and has held it in 5 quarters since. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • HFM Investment Advisors held 5 shares of Biogen worth $917 as of Q1 2026.
  • HFM Investment Advisors left its Biogen share count unchanged in Q1 2026.
  • Biogen made up ﹤0.01% of HFM Investment Advisors's portfolio in Q1 2026, its #441 holding.
  • HFM Investment Advisors first reported a position in Biogen in Q1 2025 and has held it in 5 quarters since.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on HFM Investment Advisors's 13F filing for Q1 2026, filed 1 May 2026.